Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

688068 Beijing Hotgen Biotech Co.,Ltd

54.260
+0.450+0.84%
Post Market 09/29 15:00 CCT
High
55.730
Open
54.250
Turnover
94.72M
Low
53.990
Pre Close
53.810
Volume
17.28K
Market Cap
4.99B
P/E(TTM)
3.23
52wk High
161.488
Shares
92.05M
P/E(Static)
2.29
52wk Low
50.890
Float Cap
3.52B
Bid/Ask %
100.00%
Historical High
161.488
Shs Float
64.83M
Volume Ratio
1.06
Historical Low
18.784
Dividend TTM
3.378
Div Yield TTM
--
P/B
1.49
Dividend LFY
6.23%
Div Yield LFY
--
Turnover Ratio
2.67%
Amplitude
3.23%
Avg Price
54.812
Lot Size
100
Float Cap
3.52B
Bid/Ask %
100.00%
Historical High
161.488
Shs Float
64.83M
Volume Ratio
1.06
Historical Low
18.784
Dividend TTM
3.378
Limit Up
64.570
P/B
1.49
Dividend LFY
6.23%
Limit Down
43.050
Turnover Ratio
2.67%
Amplitude
3.23%
Avg Price
54.812
Lot Size
100
Ask
7.80Klots
Bid
9.15Klots
Price Forecast

No Data

News

Comment

Company Overview More
Beijing Rejing Biotechnology Co., Ltd. (referred to as: Rejing Biology, stock code: 688068) was founded in June 2005. it is a high-tech enterprise focusing on in vitro diagnosis (IVD) in the field of biomedicine. Engaged in in vitro diagnostic reagents and instruments research and development, production and sales of biological high-tech enterprises. The company's main products are COVID-19 antigen detection products and traditional in vitro diagnostic instruments and reagent products. Corporate honors: national technological Invention Award, rare Earth Science and Technology Award, Gold Award for Independent Innovation, etc.
CEO: Changqing Lin
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...